Beijing X-Magtech Technologies, a specialist in ultra-weak magnetic field measurement technology, has reportedly secured over RMB 100 million (USD 13.8 million) in a Series A+ financing round. The funding round was led by the Beijing Robot Industry Development Investment Fund, with participation from CAS Star and existing investors including Everest Venture Capital, Zhongguancun Science City, CMBC International, and Yarui Capital. This latest round brings X-Magtech’s total funds raised to over RMB 300 million across five financing rounds.
The company had previously entered into a partnership with Fosun Medtech to collaborate on quantum precision magnetic field measurement and medical applications, focusing on marketing and brand promotion and the application of quantum magnetic field sensing technology in biological magnetic field imaging. The financial details of this partnership were not disclosed.
X-Magtech, which excels in technologies such as atomic gas chamber preparation, optoelectronic integrated chip manufacturing and packaging testing, and high-performance magnetic shielding design and manufacturing, has recently obtained marketing approval in China for its 128-channel helium-free magnetoencephalography instrument, the Marvel MEG. This instrument is recognized as the world’s highest channel count non-liquid helium magnetoencephalography device, marking a significant advancement in the field.- Flcube.com
